LFWD on Nasdaq
Lifeward Ltd.
Orthopedic company that raised $52.5 million in 2026 (SEC Form D). Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Anteris Technologies Global Corp., NutriBand Inc. or CollPlant Biotechnologies Ltd, or pick any stock.
- TickerLFWD on Nasdaq1
- IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies1
- HeadquartersHudson, Massachusetts1
- Incorporated inIsrael2
- Business address2 Cabot Road, Hudson, Ma 017492
- Filer categoryNon-accelerated filer, Smaller reporting company2
- Legal formOther
See how the biggest companies compare on our leaderboards
December 2025, we announced a distribution agreement with Verita Neuro, a provider of intensive neurological rehabilitation services.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Service And Warranty brought in 63% of the revenue Lifeward Ltd. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Service And Warranty | $2.1M | $3.2M | $3.1M |
| Lease Of Products | $1.0M | $2.6M | $1.8M |
Regions
United States brought in 60% of the revenue Lifeward Ltd. broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $7.6M | $14.4M | $13.2M |
| DEMember | $2.7M | $4.4M | $4.0M |
| Europe | $2.3M | $5.1M | $2.9M |
| Rest of World | $787.0K | $867.0K | $1.4M |
| Asia Pacific | $387.0K | $825.0K | $460.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue80¢$13.6M
- Research and development19¢$3.2M
- Income tax0¢$55.0K
Out of $1.4M in revenue.4 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $22.0M | $25.7M | $13.9M |
| Cost of revenue | $13.6M | $17.4M | $9.4M |
| Gross profit | $8.4M | $8.2M | $4.5M |
| Research and development, net | $3.2M | $4.6M | $4.1M |
| Sales and marketing | $13.9M | $17.9M | $13.9M |
| General and administrative | $8.2M | $5.2M | $10.0M |
| Impairment charges | $2.8M | $9.8M | $0 |
| Total operating expenses | $28.1M | $37.6M | $28.1M |
| Operating loss | -$19.7M | -$29.3M | -$23.6M |
| Financial (expense) income, net | -$295.0K | $448.0K | $1.5M |
| Loss before income taxes | -$20.0M | -$28.9M | -$22.1M |
| Taxes on income (benefit) | -$55.0K | $43.0K | -$12.0K |
| Net loss | -$19.9M | -$28.9M | -$22.1M |
| Net loss per ordinary share, basic | -$17.16 | -$39.96 | -$31.13 |
| Net loss per ordinary share, diluted | -$17.16 | -$39.96 | -$31.13 |
| Weighted average number of shares used in computing net loss per ordinary share, basic | 1.2M shares | 724.3K shares | 710.9K shares |
| Weighted average number of shares used in computing net loss per ordinary share, diluted | 1.2M shares | 724.3K shares | 710.9K shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $2.2M | $6.7M | ||
| Restricted cash | $240.0K | $197.0K | ||
| Trade receivables, net of credit losses of $192 and $160, respectively | $6.1M | $6.0M | ||
| Prepaid expenses and other current assets | $1.5M | $1.6M | ||
| Inventories | $5.7M | $6.7M | ||
| Total current assets | $15.8M | $21.3M | ||
| Restricted cash and other long-term assets | $209.0K | $240.0K | ||
| Operating lease right-of-use assets | $1.5M | $548.0K | ||
| Property and equipment, net | $585.0K | $867.0K | ||
| Goodwill | $4.8M | $7.5M | ||
| Total long-term assets | $7.1M | $9.2M | ||
| Total assets | $22.9M | $30.5M | ||
| Trade payables | $5.6M | $5.0M | ||
| Employees and payroll accruals | $1.4M | $1.3M | ||
| Deferred revenue | $920.0K | $1.2M | ||
| Convertible promissory notes | $2.8M | $0 | ||
| Current maturities of operating leases liability | $425.0K | $858.0K | ||
| Earnout liability | $0 | $608.0K | ||
| Other current liabilities | $859.0K | $1.2M | ||
| Total current liabilities | $12.0M | $10.2M | ||
| Deferred revenues | $1.2M | $1.3M | ||
| Non-current operating leases liability | $1.2M | $22.0K | ||
| Other long-term liabilities | $61.0K | $67.0K | ||
| Total long-term liabilities | $2.5M | $1.4M | ||
| Total liabilities | $14.5M | $11.6M | ||
| Ordinary share of NIS 1.75 par value-Authorized: 75,000,000 shares at December 31, 2025 and 25,000,000 shares at December 31, 2024; Issued: 1,572,319 and 781,854 shares at December 31, 2025 and December 31, 2024, respectively; Outstanding: 1,524,431 and 733,966 shares as of December 31, 2025 and December 31, 2024 respectively | $9.4M | $4.6M | ||
| Additional paid-in capital | $286.9M | $282.3M | ||
| Treasury Shares at cost, 47,888 ordinary shares at December 31, 2025 and December 31, 2024 | -$3.2M | -$3.2M | ||
| Accumulated deficit | -$284.7M | -$264.8M | ||
| Total shareholders' equity | $8.4M | $18.8M | $46.5M | $68.2M |
| Total liabilities and shareholders' equity | $22.9M | $30.5M | ||
| Allowance for credit losses | $192.0K | $160.0K | ||
| Ordinary shares, authorized | 75.0M shares | 25.0M shares | ||
| Ordinary shares, issued | 1.6M shares | 781.9K shares | ||
| Ordinary shares, outstanding | 1.5M shares | 734.0K shares | ||
| Treasury stock common shares | 47.9K shares | 47.9K shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $2.2M | $6.7M | ||
| Restricted cash | $240.0K | $197.0K | ||
| Trade receivables, net of credit losses of $192 and $160, respectively | $6.1M | $6.0M | ||
| Prepaid expenses and other current assets | $1.5M | $1.6M | ||
| Inventories | $5.7M | $6.7M | ||
| Total current assets | $15.8M | $21.3M | ||
| Restricted cash and other long-term assets | $209.0K | $240.0K | ||
| Operating lease right-of-use assets | $1.5M | $548.0K | ||
| Property and equipment, net | $585.0K | $867.0K | ||
| Goodwill | $4.8M | $7.5M | ||
| Total long-term assets | $7.1M | $9.2M | ||
| Total assets | $22.9M | $30.5M | ||
| Trade payables | $5.6M | $5.0M | ||
| Employees and payroll accruals | $1.4M | $1.3M | ||
| Deferred revenue | $920.0K | $1.2M | ||
| Convertible promissory notes | $2.8M | $0 | ||
| Current maturities of operating leases liability | $425.0K | $858.0K | ||
| Earnout liability | $0 | $608.0K | ||
| Other current liabilities | $859.0K | $1.2M | ||
| Total current liabilities | $12.0M | $10.2M | ||
| Deferred revenues | $1.2M | $1.3M | ||
| Non-current operating leases liability | $1.2M | $22.0K | ||
| Other long-term liabilities | $61.0K | $67.0K | ||
| Total long-term liabilities | $2.5M | $1.4M | ||
| Total liabilities | $14.5M | $11.6M | ||
| Ordinary share of NIS 1.75 par value-Authorized: 75,000,000 shares at December 31, 2025 and 25,000,000 shares at December 31, 2024; Issued: 1,572,319 and 781,854 shares at December 31, 2025 and December 31, 2024, respectively; Outstanding: 1,524,431 and 733,966 shares as of December 31, 2025 and December 31, 2024 respectively | $9.4M | $4.6M | ||
| Additional paid-in capital | $286.9M | $282.3M | ||
| Treasury Shares at cost, 47,888 ordinary shares at December 31, 2025 and December 31, 2024 | -$3.2M | -$3.2M | ||
| Accumulated deficit | -$284.7M | -$264.8M | ||
| Total shareholders' equity | $8.4M | $18.8M | $46.5M | $68.2M |
| Total liabilities and shareholders' equity | $22.9M | $30.5M | ||
| Allowance for credit losses | $192.0K | $160.0K | ||
| Ordinary shares, authorized | 75.0M shares | 25.0M shares | ||
| Ordinary shares, issued | 1.6M shares | 781.9K shares | ||
| Ordinary shares, outstanding | 1.5M shares | 734.0K shares | ||
| Treasury stock common shares | 47.9K shares | 47.9K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss | -$19.9M | -$28.9M | -$22.1M |
| Depreciation | $333.0K | $494.0K | $239.0K |
| Amortization of intangible assets | $0 | $3.3M | $1.6M |
| Impairment of intangible and tangible assets | $2.8M | $9.8M | $0 |
| Share-based compensation | $743.0K | $1.3M | $1.3M |
| Remeasurement of earnout liability | -$608.0K | -$2.7M | -$315.0K |
| Accrued interest | $442.0K | $0 | -$11.0K |
| Change in fair value of derivative liability | -$197.0K | $0 | $0 |
| Exchange rate fluctuations | -$110.0K | -$34.0K | -$45.0K |
| Trade receivables, net | -$134.0K | -$2.9M | -$311.0K |
| Prepaid expenses and other assets | $192.0K | $188.0K | -$656.0K |
| Operating lease right-of-use assets | $439.0K | $1.2M | $125.0K |
| Inventories | $896.0K | -$920.0K | -$277.0K |
| Trade payables | -$347.0K | -$47.0K | $1.0M |
| Employees and payroll accruals | $110.0K | -$702.0K | -$14.0K |
| Deferred revenues | -$419.0K | -$438.0K | -$269.0K |
| Operating lease liabilities | -$731.0K | -$1.2M | -$144.0K |
| Other liabilities | -$304.0K | -$150.0K | -$829.0K |
| Net cash used in operating activities | -$16.8M | -$21.7M | -$20.7M |
| Acquisition of a business, net of cash acquired | $0 | $0 | -$18.1M |
| Purchase of property and equipment | -$16.0K | $0 | -$81.0K |
| Net cash used in investing activities | -$16.0K | $0 | -$18.1M |
| Issuance of ordinary shares in a Registered Direct offering, net of issuance expenses in the amount of $558 | $4.4M | $0 | $0 |
| Issuance of ordinary shares under at-the-market offering, net of issuance costs of $192 | $2.6M | $0 | $0 |
| Issuance of ordinary shares in a public offering, net of issuance expenses in the amount of $432 | $2.2M | $0 | $0 |
| Purchase of treasury shares | $0 | $0 | -$992.0K |
| Proceeds from short term loan | $1.4M | $0 | $0 |
| Proceeds from bifurcated embedded derivatives | $1.6M | $0 | $0 |
| Net cash provided by (used in) financing activities | $12.2M | $0 | -$992.0K |
| Effect of Exchange rate changes on Cash, Cash Equivalents and Restricted Cash | $110.0K | $34.0K | $45.0K |
| Decrease in cash, cash equivalents, and restricted cash | -$4.5M | -$21.7M | -$39.8M |
| Classification of inventory to property and equipment, net | $35.0K | $404.0K | $481.0K |
| Expenses related to offerings not yet paid | $473.0K | $0 | $0 |
| ROU assets obtained from lease liabilities | $1.4M | $193.0K | $513.0K |
| Cash paid (received) for income taxes | $36.0K | -$7.0K | $126.0K |
| Cash received from interest | $81.0K | $654.0K | $1.3M |
No quarter-by-quarter statement was filed.
Leadership
Who has led Lifeward Ltd., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
- Chief executive officerLawrence J. Jasinski Dec 31, 2015 to now12
- Chief financial officerAlmog Adar Aug 13, 2025 to now13
- Chief financial officerMichael A. Lawless Sep 19, 2022 to May 28, 202414
- Chief financial officerOri Gon Mar 5, 2018 to Jul 1, 202115
- Chief financial officerKevin Hershberger Dec 31, 2015 to Oct 6, 201716
Board members and other officers (32)
- Chief Medical OfficerKeith Dale Rose May 20, 2026 to now17
- Chief Sales OfficerCharles Remsberg Aug 14, 2023 to Aug 14, 202318
- Director of FinanceAlmog Adar Mar 25, 2022 to Jul 3, 202319
- VP of Market Access & StrategyJeannine Lynch Aug 31, 2021 to now20
- VP Global Marktng & TrainingJodi Gricci Dec 31, 2015 to Oct 10, 201721
- VP, Regulatory and ClinicalJohn Vincent Hamilton Dec 31, 2015 to Aug 17, 201622
- Snr VP, Research & DevelopmentOfir Koren Dec 31, 2015 to Jul 7, 202023
- Board memberMiriam Kidron Mar 27, 2026 to now24
- Board memberNadav Kidron Mar 27, 2026 to now25
- Board memberYehuda Reznick Mar 27, 2026 to now26
- Board memberMoshe H. Rozenbaum Apr 13, 2026 to now27
- Board memberWilliam Mark Sigsbee Apr 13, 2026 to now28
- Board memberAvraham Gabay Aug 24, 2026 to now29
- Board memberYonason Greenwald Aug 28, 2026 to now30
- Board memberHaggai Zamir Sep 10, 2026 to now31
- Board memberMichael Swinford Apr 22, 2024 to now32
- Board memberRobert J. Marshall Jr. Nov 7, 2024 to now33
- Board memberJoseph E. Turk Jr. Apr 21, 2022 to now34
- Board memberHadar Levy Aug 24, 2022 to now35
- Board memberRandel Richner Nov 4, 2020 to now36
- Board memberChunlin Han May 23, 2019 to May 23, 201937
- Board memberYohanan Engelhardt May 10, 2018 to Aug 3, 202238
- Board memberNing Cong May 17, 2018 to Mar 29, 201939
- Board memberJay Kalish Jan 15, 2016 to Jan 15, 201640
- Board memberAryeh Dan Dec 31, 2015 to Aug 17, 202341
- Board memberDeborah Disanzo Dec 31, 2015 to May 2, 201842
- Board memberGlenn P. Muir Dec 31, 2015 to Jun 29, 201743
- Board memberJeff Dykan Dec 31, 2015 to Sep 19, 202344
- Board memberJohn William Poduska Sr. Dec 31, 2015 to now45
- Board memberLawrence J. Jasinski Dec 31, 2015 to now12
- Board memberWayne Weisman Dec 31, 2015 to Aug 3, 202246
- Board memberYasushi Ichiki Dec 31, 2015 to Aug 3, 202247
Named in SEC Form D filings
People the company listed in its private-offering notices.
Former names
Timeline
- Dec 31, 2015New chief executive Lawrence J. Jasinski becomes CEO12
Filings
353 filings to the SEC since October 2021: 8 annual reports, 15 quarterly reports, 91 major events, 134 insider forms, 13 large holders, 4 private raises, 88 other. The latest 20:
- Oct 8, 20268-K EDGAR
- Oct 1, 20268-K EDGAR
- Sep 25, 2026ARS EDGAR
- Sep 25, 2026DEF 14A EDGAR
- Sep 15, 2026PRE 14A EDGAR
- Sep 15, 20268-K EDGAR
- Sep 10, 20264 EDGAR
- Sep 10, 20263 EDGAR
- Sep 8, 20268-K EDGAR
- Sep 1, 20263 EDGAR
- Aug 31, 20268-K EDGAR
- Aug 28, 20264 EDGAR
- Aug 28, 20263 EDGAR
- Aug 24, 20264 EDGAR
- Aug 24, 20263 EDGAR
- Aug 20, 20268-K EDGAR
- Aug 14, 202610-Q EDGAR
- Aug 14, 20268-K EDGAR
- Aug 10, 2026EFFECT EDGAR
- Aug 3, 2026S-3 EDGAR
The 353 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
103 open-market trades by officers, directors and large owners since October 2021: 80 buys and 23 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2025 | Lynch JeannineVP of Market Access & Strategy | Sale | 1,591 | $0.64 | $1.0K | Form 4 |
| May 21, 2025 | Jasinski Lawrence JChief Executive Officer | Sale | 1,909 | $1.26 | $2.4K | Form 4 |
| Jan 7, 2025 | Lind Global Fund II LP10% owner | Sale | 191,434 | $1.94 | $371.9K | Form 4 |
| Jan 6, 2025 | Lind Global Fund II LP10% owner | Sale | 381,676 | $3.36 | $1.3M | Form 4 |
| Dec 13, 2024 | Richner RandelDirector | Sale | 4,285 | $1.68 | $7.2K | Form 4 |
| Dec 13, 2024 | Turk Joseph E JrDirector | Buy | 6,000 | $1.69 | $10.1K | Form 4 |
| Nov 25, 2024 | Swinford MichaelDirector | Buy | 21,622 | $2.03 | $43.9K | Form 4 |
| Nov 22, 2024 | Swinford MichaelDirector | Buy | 16,907 | $1.83 | $30.9K | Form 4 |
| Nov 20, 2024 | Swinford MichaelDirector | Buy | 16,471 | $1.84 | $30.3K | Form 4 |
| Sep 13, 2024 | Jasinski Lawrence JChief Executive Officer | Sale | 2,672 | $3.26 | $8.7K | Form 4 |
| Sep 3, 2024 | Lynch JeannineVP of Market Access & Strategy | Sale | 1,625 | $3.30 | $5.4K | Form 4 |
| Aug 2, 2024 | Jasinski Lawrence JChief Executive Officer | Sale | 2,665 | $3.84 | $10.2K | Form 4 |
| Aug 2, 2024 | Lynch JeannineVP of Market Access & Strategy | Sale | 1,783 | $3.84 | $6.8K | Form 4 |
| Jul 1, 2024 | Lynch JeannineVP of Market Access & Strategy | Sale | 1,834 | $3.83 | $7.0K | Form 4 |
| Jun 18, 2024 | Jasinski Lawrence JChief Executive Officer | Sale | 3,466 | $4.22 | $14.6K | Form 4 |
| May 23, 2024 | Lawless Michael AChief Financial Officer | Buy | 2,000 | $4.97 | $9.9K | Form 4 |
| May 23, 2024 | Turk Joseph E JrDirector | Buy | 7,916 | $5.01 | $39.7K | Form 4 |
| May 22, 2024 | Turk Joseph E JrDirector | Buy | 84 | $5.01 | $421 | Form 4 |
| May 21, 2024 | Jasinski Lawrence JChief Executive Officer | Sale | 1,620 | $4.91 | $8.0K | Form 4 |
| Nov 20, 2023 | Lind Global Fund II LP10% owner | Buy | 12,000 | $0.73 | $8.8K | Form 4 |
All 103 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- INTRACOASTAL CAPITAL, LLCSCHEDULE 13G, 3 filings Feb 11, 2022 to Jul 1, 202550
- Lind Global Fund II LPSCHEDULE 13G/A, 8 filings Oct 4, 2021 to May 15, 202551
- ARMISTICE CAPITAL, LLCSC 13G/A, 1 filing Feb 15, 202252
Money raised
Private offerings the company reported to the SEC on Form D.
- Jul 6, 2026Raised $11.2 million in a private offering of securities Form D: 5 investors so far Form D
- Mar 25, 2026Raised $20 million in a private offering of securities Form D: 2 investors so far Form D
- Jan 7, 2025Raised $5 million in a private offering of equity Form D: 4 investors so far Form D
- Sep 27, 2021Raised $16.3 million in a private offering of equity Form D: 9 investors so far Form D
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARLifeward Ltd. filings on SEC EDGAR
- 2SEC EDGARLifeward Ltd. filings on SEC EDGAR
- 3
- 4SEC EDGARLifeward Ltd. 10-K for fiscal 2025
- 5SEC EDGARLifeward Ltd. 10-K for fiscal 2019
- 6SEC EDGARLifeward Ltd. 10-K for fiscal 2020
- 7SEC EDGARLifeward Ltd. 10-K for fiscal 2022
- 8SEC EDGARLifeward Ltd. 10-K for fiscal 2023
- 9SEC EDGARLifeward Ltd. 10-K for fiscal 2024
- 10SEC EDGARLifeward Ltd. 10-Q for fiscal 2026
- 11SEC EDGARLifeward Ltd. 10-Q for fiscal 2026
- 12
- 13SEC EDGARAlmog Adar, Chief financial officer
- 14
- 15SEC EDGAROri Gon, Chief financial officer
- 16
- 17
- 18
- 19SEC EDGARAlmog Adar, Director of Finance
- 20
- 21
- 22
- 23
- 24SEC EDGARMiriam Kidron, Board member
- 25SEC EDGARNadav Kidron, Board member
- 26SEC EDGARYehuda Reznick, Board member
- 27SEC EDGARMoshe H. Rozenbaum, Board member
- 28SEC EDGARWilliam Mark Sigsbee, Board member
- 29SEC EDGARAvraham Gabay, Board member
- 30SEC EDGARYonason Greenwald, Board member
- 31SEC EDGARHaggai Zamir, Board member
- 32SEC EDGARMichael Swinford, Board member
- 33SEC EDGARRobert J. Marshall Jr., Board member
- 34SEC EDGARJoseph E. Turk Jr., Board member
- 35SEC EDGARHadar Levy, Board member
- 36SEC EDGARRandel Richner, Board member
- 37SEC EDGARChunlin Han, Board member
- 38SEC EDGARYohanan Engelhardt, Board member
- 39SEC EDGARNing Cong, Board member
- 40SEC EDGARJay Kalish, Board member
- 41SEC EDGARAryeh Dan, Board member
- 42SEC EDGARDeborah Disanzo, Board member
- 43SEC EDGARGlenn P. Muir, Board member
- 44SEC EDGARJeff Dykan, Board member
- 45
- 46SEC EDGARWayne Weisman, Board member
- 47SEC EDGARYasushi Ichiki, Board member
- 48
- 49
- 50
- 51
- 52